Stem cells · Lesson 1 of 8 · 3 min

What is a stem cell?

Stem cells are defined by two properties: self-renewal and the capacity to differentiate. Here is what that means and where clinical use stands.

A researcher looking into a microscope

Key takeaways.

  • Two properties define every stem cell: self-renewal and differentiation capacity.
  • Asymmetric division yields one stem cell and one differentiated cell, which keeps the stem cell pool intact.
  • Hematopoietic stem cells sit mainly in bone marrow and generate all blood and immune cells.
  • Mesenchymal stem/stromal cell (MSC) research traces back to bone marrow work in the 1970s.
  • Stem cell therapies are not FDA-approved for the orthopaedic, pain and aesthetic uses that clinics market.

Two properties define a stem cell

A stem cell is defined by two properties. Self-renewal means the cell can divide and keep its own population going. Differentiation capacity means it can also give rise to specialized cells.

Asymmetric division is one way a cell does both. A single division produces one stem cell and one differentiated cell. This maintains the stem cell pool while supplying specialized cells, and it is essential for tissue homeostasis, the steady upkeep of a tissue.

How the field got here

The first evidence of stem cells came in the early 1960s. James Till and Ernest McCulloch, two Canadian researchers, irradiated mice and saw colonies form in the spleen after bone marrow transplantation.

In the 1970s, Alexander Friedenstein identified adherent bone marrow cells that formed colonies and could form bone and cartilage. That work is the foundation of mesenchymal stem/stromal cell (MSC) research. In 2006, Shinya Yamanaka showed that four factors could reprogram adult cells into pluripotent stem cells.

Two adult stem cell types to know

Hematopoietic stem cells (HSCs) reside mainly in bone marrow and generate all blood and immune cells. The course material describes HSC transplantation as the most established stem cell therapy.

MSCs are the cells most often discussed in regenerative medicine research. The course describes them as having more clinical trials than any other stem cell population.

Where clinical use stands

Some stem cell approaches are being investigated in clinical trials, and most applications remain investigational. Stem cell therapies are not FDA-approved for the orthopaedic, pain and aesthetic uses that clinics market. Clinicians therefore need to be able to evaluate the evolving evidence themselves.

Educational content for healthcare professionals. Not a treatment recommendation. Stem cell therapies are not FDA-approved for the orthopaedic, pain and aesthetic uses most clinics offer.

Stem cells: 0 of 8 lessons finished

All lessons

This guide covers the what and the why.

The how is taught live. The webinar and live training go deeper on:

  • The molecular controls of stem cell fate
  • How to read and weigh stem cell study evidence
  • How the main stem cell types compare for research use
  • Regulatory questions to settle before offering any cell product

Common questions.

What makes a stem cell different from other cells?
Two properties. It can renew its own population, and it can give rise to specialized cells.
Are stem cell therapies FDA-approved?
Stem cell therapies are not FDA-approved for the orthopaedic, pain and aesthetic uses that clinics market. Most applications remain investigational.

Sources

  • Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015;35(2):e00191.
  • Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: An update. Cell Transplant. 2016;25(5):829-48.

Ready for the hands-on detail?

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.